Rabeprazole Hydroxy Compound CAS 675198-19-3 Purity >99.5% (HPLC) Factory

Short Description:

Chemical Name: [4-(3-Methyoxypropoxy)-3-Methyl-2-Pyridinyl]methanol Hydrochloride

Synonyms: Rabeprazole Hydroxy Compound

CAS: 675198-19-3

Purity: >99.5% (HPLC)

Appearance: Light Yellow Crystalline Powder

Intermediate of Rebeprazole Sodium CAS 117976-90-6

E-Mail: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Ruifu Chemical Supply Rabeprazole Sodium Intermediates
Rabeprazole Sodium CAS 117976-90-6
Rabeprazole Hydroxy Compound CAS 675198-19-3
Rabeprazole Chloride Compound CAS 153259-31-5

Chemical Properties:

Chemical Name	[4-(3-Methyoxypropoxy)-3-Methyl-2-Pyridinyl]methanol Hydrochloride
Synonyms	Rabeprazole Hydroxy Compound; (4-(3-Methoxypropoxy)-3-Methylpyridin-2-yl)methanol Hydrochloride; 4-(3-Methoxypropoxy)-3-Methylpyridine-2-Methanol Hydrochloride
CAS Number	675198-19-3
CAT Number	RF-PI1919
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C11H18ClNO3
Molecular Weight	247.72
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	Light Yellow Crystalline Powder
Assay / Analysis Method	>99.5% (HPLC)
Loss on Drying	<0.50%
Residue on Ignition	<0.20%
Any Single Impurity	<0.50%
Total Impurities	<0.50%
Heavy Metals	<20ppm
Test Standard	Enterprise Standard
Usage	Intermediate of Rebeprazole Sodium (CAS: 117976-90-6)

Rabeprazole Hydroxy Compound CAS 675198-19-3 Synthetic Route

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture

Advantages:

FAQ:

Application:

[4-(3-Methyoxypropoxy)-3-Methyl-2-Pyridinyl]methanol Hydrochloride, Rabeprazole Hydroxy Compound, (CAS: 675198-19-3) is an intermediate of Rebeprazole Sodium (CAS: 117976-90-6). Rabeprazole sodium azole canker is a proton pump inhibitor class taking the drugs, for ray Bella azole sodium salt form, first by the Japanese Eisai company successfully developed for the first time, name of commodity for wave force, the role of proton pump inhibitors is to reduce gastric acid secretion of stable disease areas, so as to cure the stomach and duodenal ulcers and stomach esophagus regurgitation disease effect. It is mainly used in clinical treatment of acid-related diseases, such as gastric and duodenal ulcer selection, peptic ulcer, gastroesophageal reflux disease, zhuoye syndrome and so on. Rebeprazole sodium has a faster onset of action compared with omeprazole, but a shorter duration of action. Rabeprazole is a benzimidazole substitute that inhibits gastric acid secretion by binding to the proton pump of gastric parietal cells. This product inhibits the action of adenosine triphosphate, a key enzyme in the production of gastric acid. It can inhibit the secretion of basic gastric acid and gastric acid caused by stimulation.